| |
Acute diarrhoeas often
resulting from an infection of the intestinal tract. The infectious
agents, viruses, bacteria, or parasites, entering the intestinal
tract act directly on the luminal side of the enterocytes. The loss
of water and electrolytes produces dehydration, the severity of
which depends upon the frequency of diarrhoea and the amount of
water and electrolyte loss.
The circulation of water in the intestine
The disturbances of the entero-systemic cycle of water explain the
signs and symptoms of diarrhoea1,2. The enterocytes covering
the intestinal wall can present with 2 types of disturbances.
- Infectious agents stimulate secretion to such an extent that
it exceeds the re-absorptive capacity for water and electrolytes,
- The re-absorption capacity is diminished and becomes unable
to cope with the amounts secreted
The first mechanism is that of the secretory diarrhoeas,
caused e.g. by the toxins of Vibrio cholerae or Escherichia coli3.
The second one implies destruction of the enterocytes and their
increased regeneration, as seen in rotavirus infections4,5.
The role of the enterocytes
Diarrhoea can be considered as a disturbance of the enterocyte transport
systems. There is an increased Cl- secretion and a decreased absorption
of NaCl. These two mechanisms have an additive effect, causing an
accumulation of water and electrolytes in the intestinal lumen.
The glucose-driven sodium absorption is usually conserved6. It decreases,
however, in rotavirus or cryptosporidium infections7-9 and may increase
in cholera. At the level of the colon, it should be possible to
stimulate sodium absorption by the short chain fatty acids produced
by the fermentation of carbohydrates10-14.
The secretory immunoglobulins barrier
An infection of the intestine quickly gives rise to the recognition
of microbial antigens by the mucosa-associated lymphoid tissue present
in the Peyer's patches of the small intestine. Activated specific
lymphocytes and memory cells spread all over the intestinal mucosa.
The resulting mature plasmocytes produce immunoglobulin A (IgA)
that binds to a specific receptor, the secretory piece, derived
by proteolytic cleavage from the basal membrane of the enterocytes.
The tetravalent dimeric secretory IgA enters the gut and binds specifically
to the infecting micro-organisms in the intestinal lumen and the
mucous covering the enterocytes. This leads to a very efficient
"immunological exclusion" preventing the contact between
microbial antigens and enterocytes. Daily, more than 3 gram of IgA
reach the mucosal secretions15, blocking the massive entry of pathogens
in the body. There is experimental proof in vivo that IgA alone
can protect the gut from bacterial colonisation and the ensuing
diarrhoea. For example, the induced secretion of a monoclonal IgA
directed against a glycosylated epitope of the surface lipopolysaccharide
of V. cholerae protects infected mice from diarrhoea and death16.
These studies underscore the powerful protective effect on the intestinal
mucosa of specific IgA, if present in sufficient amounts. This has
been convincingly demonstrated in rotavirus infection17-19.
Infectious agents act directly on the epithelium
Despite the protective systems of the mucosa, infectious agents
can directly lock on to the enterocytes. This results in changes
of the concentrations of intracellular messengers that, in turn,
acting on phosphorylation mechanisms, modify the concentration or
the activity of the transport systems of the cellular membrane20,21.
The B-subunit of cholera toxin binds to the GM1 gangliosides of
the luminal membranes of the enterocytes. It allows the A-subunit
to enter the cell and stimulate adenylate cyclase, an enzyme of
the basolateral cell membrane. This causes a rise of cyclic AMP
and an increased phosphorylation by protein kinase of the transport
proteins located in the luminal membrane. The transport proteins
include CFTR protein and NHE3 protein. The former activates the
selective Cl- secretion channel, and the latter inhibits active
coupled NaCl absorption from the mucosal to the serosal side of
the gut. Beside V. cholerae, all other infectious agents that act
directly on the enterocytes use similar mechanisms, though the membrane
receptors are not necessarily GM1 gangliosides and the intracellular
messengers include cyclic GMP, cytosolic Ca++ or IP3, all of which
modulate the expression of the cellular transport systems3,22-30.
Infectious agents also act on the enterocytes by way of the
cells of the lamina propria
One of the most striking aspects of the pathophysiology of acute
infectious diarrhoeas is that the infectious agents act not only
directly on the enterocytes and their secretion and absorption of
water and electrolytes. They also act on the complex structures
of the lamina propria surrounding the intestinal epithelium. The
lamina propria consists of a great variety of cells, including nervous
and neuro-endocrine cells, lymphocytes, polymorphonuclear and eosinophilic
leukocytes, macrophages, mastocytes and myofibroblasts. Once stimulated,
all these cells interact and influence the function of the enterocytes.
Taking into account the multiple interactions between the infectious
agents and the whole intestinal mucosa (enterocytes and cells of
the lamina propria), one can divide the pathophysiological mechanisms
of diarrhoeas in 4 broad categories21.
- The action of enterotoxins
- The action of cytotoxins
- The adherence of infectious agents on the enterocytes,
- The invasion of, and effect on, the lamina propria through the
epithelium.
Each of these mechanisms exerts their actions directly on the enterocytes
and indirectly on the lamina propria.
The 3 other mechanisms also affect both the enterocytes (directly)
and the lamina propria cells (indirectly). These produce many mediators
acting on their own environment, on the enterocytes and, at a distance,
on other parts of the organism. These mediators include neuro-mediators,
such as serotonin and acetylcholine, vasoactive intestinal polypeptide
(VIP), the arachidonic acid cascade, i.e. prostaglandins, thromboxanes
and leukotrienes, and cytokines, such as TNFa and interferon-g,
free radicals, nitric oxide (NO), and many other mediators of inflammation.
Dynamic aspects
One of the remarkable features of the small intestinal epithelium
is that the enterocytes covering this considerable surface - when
the microvilli are included it has been estimated at not less than
340,000 square cm for a 1 year old child are renewed on average
every 72 hours. This is a result of the cellular cycle of the stem
cells, located at the bottom of the crypts, and, at least in part,
driven by substances secreted by cells of the lamina propria. They
include cytokines, such as TNFa and IL-6, growth factors, such as
epidermal growth factor, (EGF) and hormones, such as norepinephrine
and tri-iodothyronine. Immunological diseases, e.g. coeliac disease
and host-versus-graft reaction, influence the structure and speed
of renewal of the enterocytes. Similar changes occur in acute diarrhoeas.
This has been observed in transmissible gastro-enteritis (TGE) of
piglets that has many similarities with rotavirus infections in
children7,9. There is a partial destruction of the villi with an
accelerated renewal of the enterocytes. The result is a decrease
of the absorptive surface, and a reduction of the absorption of
sodium-coupled glucose and amino acids, and NaCl. These anomalies
takes place by stimulation of lamina propria cells. Also, in cryptosporidiosis,
which is not considered an invasive infection, there are morphological
and functional lesions, resembling an inflammatory infiltrate in
the lamina propria8.
Normal intestinal variations
Food intolerance or sensitivity
Intestinal infections
Most of these are not serious, not treatable, and will resolve
on their own with time:
- Rotavirus : One of the most common causes of diarrhoea, especially
during late fall and winter months. It causes very foul smelling,
watery, green or brown diarrhoea that can persist for weeks. Fever
and vomiting are common at the onset of the illness.
- Other viruses : There are a variety of these, none of which
are serious.
- Bacteria : These include E. Coli, Salmonella, and several others.
Vomiting and fever may be present at the onset. Blood in the diarrhoea
is a common finding with bacterial infections. Even these infections
rarely require antibiotic treatment.
- Parasites : There are a variety of these. They are usually caught
from contaminated water (e.g. giardia) or during travel to foreign
countries. The telltale sign of a parasite is very watery diarrhoea
that lasts beyond two weeks.
- Contagious : These are all generally contagious as long as the
diarrhoea continues.
Mechanisms of diarrhoea:
There are at least 5 potential mechanisms which can produce diarrhoea:
- Motility disorders : Rapid transit with incomplete absorption
- Irritable bowel syndrome
- Carcinomas
- Osmotic disorders : Osmotically active substances are not properly
absorbed
- Lactose intolerance in children
- Permeability defects : Distorted mucosal architecture results
in impaired permeability
- Coeliac disease
- Inflammatory bowel disease
- Active transport disorders : Impaired membrane transporters
- Secretory diarrhoeal disease : Stimulation of intestinal secretory
process without changes in histology
Cholera toxin : This is the best recognised of the secretory stimuli.
Patients can loose 10-20 litres of fluid per day, which leads to
rapid dehydration and death. Toxin attaches itself to specific receptors
and enters the cell where it stimulates secretion. The specific
mechanism is the production of cAMP, which opens specific apical
membrane Cl- channels. Opening of this channel effectively reverses
the usual ionic fluxes with the result that ions and water are secreted
into the intestinal lumen.
- Heat stable and head labile E. coli toxins.
Management of diarrhoea
· If the diarrhoea is accompanied by fever and maybe vomiting,
then it is probably an intestinal viral or bacterial infection.
· Rule out milk allergy / milk intolerance
· Rule out food allergy : Eliminate irritating foods.
· Cow's milk-based formula : If the diarrhoea is severe and
has lasted more than 3 days, we suggest you switch to a soy formula
for two weeks while the intestines have time to heal. Intestines
that have been damaged by severe diarrhoea cannot digest cow's milk.
Clinical Abstract of the Study on New Diarex
Atisara (Diarrhoea) is one of the common problems of the patients
attending the Ayurvedic outpatient department of any Ayurvedic hospital.
In Ayurveda, Diarrhoea has been classified in two broad groups
depending upon mature stools and immature stools. They have been
termed as Atisara and Ama-Atisara respectively. In Ama-Atisara there
is a foul smell and is associated with painful flatulence, distressing
constipation, abdominal pain, excess salivation and nausea. In case
of Atisara excess liquidity, compactness, coldness and presence
of mucous is reported by the patients.
Thirty patients of either sex in the age group of 16-70 years were
selected from the outpatient department of Dravyaguna, Sir Sunder
Lal Hospital, Banaras Hindu University, Varanasi.
The new antidiarrheal drug New Diarex was supplied by The Himalaya
Drug Company, Bangalore. The patients were given New Diarex at dose
of 2 tablets three times a day for 7 days and 2 tablets two times
a day for subsequent 7 days to be taken after meals.
The patients were divided into 4 age groups i.e. 16-20 years, 31-45
years; 40-60 years; and 61-75 years. The maximum number of patients
13(43.3%) belonged to 16-30 years. Next to it 9(30%) belonged to
31-45 years. And 5(16.7%) belonged to 61-75 years and only 3(10%)
belonged to 46-60 years of age group. Out of the 30 patients 18(60%)
were male and 12(40%) females.
The majority of patients reported foul smell of stools and associated
with painful flatulence and abdominal pain. Excess liquidity, nausea,
anorexia, constipation and mucous was observed less frequently.
Twenty seven (90%) patients reported 3-6 loose motions per day
and 3(10%) had 7-10 per day. Foul smell was reported by 25(83.4%)
cases, painful defecation by 27(90%) cases; abdominal pain by 15(50%)
cases; excess liquidity by 5(17%) cases; nausea by 12(40%) cases;
anorexia by 9(30%) cases and mucous by 6(20%) cases.
Loose motions reduced in 90% of cases after seven days of treatment
at a dose of 2 tablets three times a day. Foul smell was found absent
in 80% of cases; painful defecation in 77.7% of cases; abdominal
pain in 66.6% of cases; excess liquidity in 40% of cases; nausea
in 75% of cases; anorexia in 66.6% of cases and mucous in 80% of
cases.
Relief in loose motions was reported by almost all the cases except
one case in which liquidity was persisting. Painful defecation,
abdominal pain and nausea was also found significantly controlled
by majority of the patients.
New Diarex is effective in Ama-Atisara group of patients than the
Atisara patients. The symptoms like painful defecation, abdominal
pain and nausea subsided in all the cases after fifteen days of
treatment. The findings suggest that New Diarex is effective in
Atisara as it contains Holarrhena antidysenterica, Aegle marmelos,
Punica granatum and Cyperus rotundus. These ingredients also contain
Tikta Rasa, which have been used in the treatment of Ama-Atisara
in Ayurveda.
We are thankful to Dr. S.K. Mitra,
Executive Director, Research & Technical Services, The Himalaya
Drug Company, Bangalore, for the trial drug New Diarex and other
assistance.
- Desjeux JF,
Tannenbaum C, Tai YH, Curran PF. Effects of sugars and amino acids
on sodium movement across small intestine. Am. J. Dis. Child 1977;131:331-340.
- Phillips
SF. Diarrhea: a current view of the pathophysiology. Gastroenterology
1972;63:495-518.
- Nath SK,
Huang X, L'helgoualc'h A, Rautureau M, Bisalli A, et al. Relation
between chloride secretion and intracellular cyclic adenosine
monophosphate in a cloned human intestinal cell line HT-29 cl
19A. Gut 1994;35:631-636.
- Davidson
GP, Gall DG, Petric M, Butler DG, Hamilton JR. Human rotavirus
enteritis induced in conventional piglets. Intestinal structure
and transport. J. Clin. Invest. 1977;60:1402-1409.
- Davidson
GP, Barnes GL. Structural and functional abnormalities of the
small intestine in infants and young children with rotavirus enteritis.
Acta. Paediatr. Scand. 1979;68:181-186.
- Grasset E,
Heyman M, Dumontier AM, Lestradet H, Desjeux JF. Possible sodium
and D?glucose cotransport in isolated jejunal epithelium of children.
Pediatr. Res. 1979;13:1240-1246.
- McClung HJ,
Butler DG, Kerzner B, Gall DH, Hamilton JR. Transmissible gastroenteritis.
Mucosal ion transport in acute viral enteritis. Gastroenterology
1976;70:1091-1095.
- Argenzio
RA, Liacos JA, Levy ML, Meuten DJ, Lecce JG, Powell DW. Villous
atrophy, crypt hyperplasia, cellular infiltration, and impaired
glucose-Na absorption in enteric cryptosporidiosis of pigs. Gastroenterology
1990;98:1129-1140.
- Butler DG,
Gall DG, Kelly MH, Hamilton JR. Transmissible gastroenteritis.
Mechanisms responsible for diarrhea in an acute viral enteritis
in piglets. J. Clin. Invest. 1974;53:1335-1342.
- Desjeux JF,
Ramakrishna BS. Resistant starch as adjuvant in oral rehydration
solutions for the treatment of diarrhea. Nestlé Foundation.
Annual report, 1987:75-100.
- Binder HJ,
Mehta P. Short-chain fatty acids stimulate active sodium and chloride
absorption in vitro in the rat distal colon. Gastroenterology
1989;96:989-996.
- Phillips
SF, Giller J. The contribution of the colon to electrolyte and
water conservation in man. J. Lab. Clin. Med. 1973;81:733-746.
- Argenzio
RA, Moon HW, Kemeny LJ, Whipp SC. Colonic compensation in transmissible
gastroenteritis of swine. Gastroenterology 1984;86:1501-1509.
- Rajendran
VM, Binder HJ. Apical membrane Cl-butyrate exchange: mechanism
of short chain fatty acid stimulation of active chloride absorption
in rat distal colon. J. Membr. Biol. 1994;141:51-58.
- Kraehenbuhl
JP, Neutra MR. Molecular and cellular basis of immune protection
of mucosal surfaces. Physiol. Rev. 1992;72:853-879.
- Winner L,
III, Mack J, Weltzin R, Mekalanos JJ, Kraehenbuhl JP, Neutra MR.
New model for analysis of mucosal immunity: Intestinal secretion
of specific monoclonal immunoglobulin A from hybridoma tumors
protects against Vibrio cholerae infection. Infect. Immun. 1991;59:977-982.
- Guarino A,
Casola A, Bruzzese E, Saini M, Nitsch L, Rubino A. Human serum
immunoglobulin counteracts rotaviral infection in Caco-2 cells.
Pediatr. Res. 1996;40:881-887.
- Guarino A.
Active treatment of viral diarrhea with passive immunotherapy.
J. Pediatr. Gastroenterol. Nutr. 1996;23:337.
- Mitra AK,
Mahalanabis D, Ashraf H, Unicomb L, Eeckels R, et. al. Hyperimmune
cow colostrum reduces diarrhoea due to rotavirus: A double-blind,
controlled clinical trial. Acta Paediatr. 1995;84:996-1001.
- Powell DW.
New paradigms for the pathophysiology of infectious diarrhea (Editorial
comment). Gastroenterology 1994;106:1705-1707.
- Crowe SE,
Powell DW. Fluid and electrolyte transport during enteric infections.
In: Infections of the gastrointestinal tract. Blaser MJ, Smith
PD, Ravdin JI, et. al. (Eds.). New York: Raven; 1995:107-141.
- Huang XP,
Heyman M, Nath SK, Castagna M and Desjeux JF. Distinct signalling
mediates chloride secretion induced by tumor promoter bile salts
and phorbol esters in human colonic cells. Int. J. Oncol. 1995;6:1159-1163.
- Battu S,
Clément G, Heyman M, Wal JM, Cook-Moreau J, et al. Production
of arachidonic acid metabolites by the colon adenocarcinoma cell
line HT29 cl.19A and their effect on chloride secretion. Cancer
Lett. 1997;116:213-223.
- Hyun CS,
Binder HJ. Mechanism of leukotriene D4 stimulation of Cl- secretion
in rat distal colon in vitro. Am. J. Physiol. 1993;265:G467-G473.
- Peterson
JW, Whipp SC. Comparison of the mechanisms of action of cholera
toxin and the heat-stable enterotoxins of Escherichia coli. Infect.
Immun. 1995;63:1452-1461.
- Beubler E,
Schirgi-Degen A, Pabst MA, Pothoulakis C, LaMont JT. Effects of
purified Clostridium difficile toxin A in the small intestine
of the rat in vivo. Nat. Toxins. 1993;1:369-375.
- Peterson
JW, Cantu J, Duncan S, Chopra AK. Molecular mediators formed in
the small intestine in response to cholera toxin. J. Diarrhoeal.
Dis. Res. 1993;11:227-234.
- Eklund S,
Brunsson I, Jodal M, Lundgren O. Changes in cyclic 3'5'-adenosine
monophosphate tissue concentration and net fluid transport in
the cat's small intestine elicited by cholera toxin, arachidonic
acid, vasoactive intestinal polypeptide and 5-hydroxytryptamine.
Acta Physiol. Scand. 1987;129:115-125.
- Liang YF,
Peterson JW, Reitmeyer JC. Inhibitory effect of aspirin on cholera
toxin-induced phospholipase and cyclo-oxygenase activity. FEMS
Microbiol. Lett. 1990;60:137-141.
- Farris RK,
Tapper EJ, Powell DW, Morris SM. Effect of aspirin on normal and
cholera toxin-stimulated intestinal electrolyte transport. J.
Clin. Invest. 1976;57:916-924.
|
 |